Clinical and novel application of FibroScan, FIB‐4 and aspartate aminotransferase‐to‐platelet ratio index in liver fibrosis evaluation in patients with hepatocellular carcinoma and their roles in oesophageal variceal prediction

Background Non‐invasive techniques for liver fibrosis diagnosis are very important for clinician especially in high‐risk patients for liver biopsy. We further explored the diagnostic accuracy of FibroScan, FIB‐4 and aminotransferase‐to‐platelet ratio index (APRI) in identifying liver fibrosis and assess their predictive role for oesophageal varices in patients with hepatocellular carcinoma (HCC). Methods In total, 380 patients who underwent surgery for HCC were included based on retrospective study design. Liver fibrosis was pathologically diagnosed using the Ishak scoring system. Liver stiffness parameters were measured using FibroScan. APRI and FIB‐4 were calculated. Among those, 121 patients who received oesophagogastroduodenoscopic examination underwent variceal evaluation. Results For liver cirrhosis diagnosis with FibroScan, the optimal cut‐off values for the patients with HCC overall, left HCC and right HCC were 8.85, 11.75 and 8.70 kPa (the accuracy were 78.7%, 78.4% and 79.2%, respectively). They had high areas under the receiver operating characteristic curve of 0.84, 0.84 and 0.85. The combined FibroScan, APRI and FIB‐4 had very high specificity (more than 92%) for cirrhosis diagnosis. The optimal cut‐off liver stiffness values for the diagnosis of varices were all 11.2 kPa. For predicting varices, the optimal cut‐off values of FIB‐4 and APRI were 2.64 and 0.71, their accuracy were 64.3%‐78.4%, 69.4% and 72.7%, respectively. Conclusions FibroScan, FIB‐4 and APRI have moderate accuracy for liver fibrosis diagnosis and oesophageal varices prediction in patients with hepatoma. This is a study of these non‐invasive techniques applied in specific hepatoma patients and with inevitable limitations and need future more studies for validation.